Exciting news from our portfolio company – Attomarker handheld will be launched from Exeter, UK in 2025, and many believe it will be transformative for human (and animal) health.
Capable of performing multiple tests simultaneously in minutes from a fingerprick sample. Forthcoming tests include human infection, women’s health and liver health.
The test to provide information on antibody spectrum responses to Long Covid has just been CE marked: https://www.bbc.com/news/articles/c4g7722wxj4o
Attomarker is revolutionising healthcare with rapid fingertip tests that empower personalised medicine, improve outcomes and is paving the way for faster, smarter, and more accessible diagnostics worldwide.
💡𝐊𝐞𝐲 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬:
▪️ 𝐑𝐚𝐩𝐢𝐝 𝐓𝐞𝐬𝐭𝐢𝐧𝐠: Diagnoses bacterial, viral, or co-infections in minutes, reducing hospitalisations and unnecessary antibiotics.
▪️ 𝐋𝐨𝐧𝐠 𝐂𝐨𝐯𝐢𝐝 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬: Tailored immunity profiles to guide precise care and booster timing.
▪️ 𝐏𝐨𝐫𝐭𝐚𝐛𝐥𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐃𝐞𝐯𝐢𝐜𝐞𝐬: Point-of-care testing for human and animal health, even in remote areas.
▪️ 𝐀𝐈-𝐃𝐫𝐢𝐯𝐞𝐧 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: Advanced platforms for unparalled accuracy and predictive health analytics.
▪️ 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐯𝐞 𝐆𝐫𝐨𝐰𝐭𝐡: Partnerships driving groundbreaking diagnostics and patient-centered solutions.
Categories: News
Tags: Impact Milltrust Technology